|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Depreciation of property and equipment | |||||
| Amortization of intangible assets | |||||
| Change in fair value of warrant liabilities | |||||
| Allowance for credit losses | |||||
| Amortization of investment discount | |||||
| Asset write-down | |||||
| Goodwill impairment | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Unbilled receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Operating lease assets & other non-current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Other non-current liabilities | |||||
| Accrued liabilities and current operating lease liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Acquisition of a business, net of cash acquired | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under ESPP | |||||
| Proceeds from the exercise of warrants | |||||
| Shares repurchased for payment of tax withholdings | |||||
| Payment of obligations under capital leases | |||||
| Payment of obligations under finance leases | |||||
| Payment of debt obligations | |||||
| Proceeds from the issuance of warrants | |||||
| Proceeds from issuance of common stock | |||||
| Payment of transaction costs related to issuance of common stock | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash activities: | |||||
| Purchases of property and equipment financed through notes payable | |||||
| Common stock issued in connection with a business acquisition | |||||
| Warrant liabilities reclassified to equity upon exercise | |||||
Loading...